Neurotrophic signaling molecules associated with cholinergic damage in young and aged rats: Environmental enrichment as potential therapeutic agent

Neurobiology of Aging

Volumn 32, Issue 3, 2011, Pages 470-485

  Paban, Véronique ^a   Chambon, Caroline ^a   Manrique, Christine ^a   Touzet, Claude ^a   Alescio Lautier, Béatrice ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

192 IgG saporin; Bdnf; GE array; Immunohistochemistry; T maze

Indexed keywords

AGING; ANIMAL HOUSING; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENVIRONMENTAL ENRICHMENT; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLIA CELL; MALE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN PROCESSING; PSYCHOTHERAPY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79952988579     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.03.010     Document Type: Article

References (110)

1. Bartus R.T. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol. 2000, 163:495-529.
2. Bates B., Hirt L., Thomas S.S., Akbarian S., Le D., Amin-Hanjani S., Whalen M., Jaenisch R., Moskowitz M.A. Neurotrophin-3 promotes cell death induced in cerebral ischemia, oxygen-glucose deprivation, and oxidative stress: possible involvement of oxygen free radicals. Neurobiol. Dis. 2002, 9:24-37.
3. Baxter M.G., Chiba A.A. Cognitive functions of the basal forebrain. Curr. Opin. Neurobiol. 1999, 9:178-183.
4. Baxter M.G. Effects of selective immunotoxic lesions on learning and memory. Methods Mol. Biol. 2001, 166:249-265.
5. Bayatti N., Behl C. The neuroprotective actions of corticotropin releasing hormone. Ageing Res. Rev. 2005, 4:258-270.
6. Bayer L., Serafin M., Eggermann E., Saint-Mleux B., Machard D., Jones B.E., Mühlethaler M. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J. Neurosci. 2004, 24:6760-6764.
7. Bensadoun J.C., de Almeida L.P., Dréano M., Aebischer P., Déglon N. Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome. Eur. J. Neurosci. 2001, 11:1753-1761.
8. Bevan S., Vakharia V., Parker D. Changes in gene expression and integrin-mediated structural changes are associated with long-term plasticity of a spinal cord locomotor network. Neuroscience 2008, 152:160-168.
9. Blalock E.M., Chen K.C., Sharrow K., Herman J.P., Porter N.M., Foster T.C., Landfield P.W. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J. Neurosci. 2003, 23:3807-3819.
10. Branchi I., Francia N., Alleva E. Epigenetic control of neurobehavioural plasticity: the role of neurotrophins. Behav. Pharmacol. 2004, 15:353-362.
11. Carrasco J., Penkowa M., Giralt M., Camats J., Molinero A., Campbell I.L., Palmiter R.D., Hidalgo J. Role of metallothionein-III following central nervous system damage. Neurobiol. Dis. 2003, 13:22-36.
12. Carter A.R., Chen C., Schwartz P.M., Segal R.A. Brain-derived neurotrophic factor modulates cerebellar plasticity and synaptic ultrastructure. J. Neurosci. 2002, 22:1316-1327.
13. Casu M.A., Wong T.P., De Koninck Y., Ribeiro-da-Silva A., Cuello A.C. Aging causes a preferential loss of cholinergic innervation of characterized neocortical pyramidal neurons. Cereb. Cortex. 2002, 12:329-337.
14. Chambon C., Paban V., Manrique C., Alescio-Lautier B. Behavioral and immunohistological effects of cholinergic damage in immunolesioned rats: alteration of c-Fos and polysialylated neural cell adhesion molecule expression. Neuroscience 2007, 147:893-905.
15. Chen Q., Smith G.M., Shine H.D. Immune activation is required for NT-3-induced axonal plasticity in chronic spinal cord injury. Exp. Neurol. 2008, 209:497-509.
16. Cheng X.R., Zhou W.X., Zhang Y.X., Zhou D.S., Yang R.F., Chen L.F. Differential gene expression profiles in the hippocampus of senescence-accelerated mouse. Neurobiol. Aging 2007, 28:497-506.
17. Cotman C.W., Berchtold N.C. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 2002, 25:295-301.
18. Covey M.V., Levison S.W. Leukemia inhibitory factor participates in the expansion of neural stem/progenitors after perinatal hypoxia/ischemia. Neuroscience 2007, 148:501-509.
19. Cregan S.P., Fortin A., MacLaurin J.G., Callaghan S.M., Cecconi F., Yu S.W., Dawson T.M., Dawson V.L., Park D.S., Kroemer G., Slack R.S. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell. Biol. 2002, 158:507-517.
20. De March Z., Zuccato C., Giampà C., Patassini S., Bari M., Gasperi V., De Ceballos M.L., Bernardi G., Maccarrone M., Cattaneo E., Fusco F.R. Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions. Neuroscience 2008, 152:734-740.
21. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4:3-7.
22. Dhandapani K.M., Hadman M., De Sevilla L., Wade M.F., Mahesh V.B., Brann D.W. Astrocyte protection of neurons: role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway. J. Biol. Chem. 2003, 278:43329-43339.
23. Dickinson-Anson H., Winkler J., Fisher L.J., Song H.J., Poo M., Gage F.H. Acetylcholine-secreting cells improve age-induced memory deficits. Mol. Ther. 2003, 8:51-61.
24. Draghici S., Khatri P., Bhavsar P., Shah A., Krawetz S.A., Tainsky M.A. Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare Onto-Design and Onto-Translate. Nucleic Acids Res. 2003, 31:3775-3781.
25. Ferrer I., Planas A.M. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J. Neuropathol. Exp. Neurol. 2003, 62:329-339.
26. Fibiger H.C. The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res. 1982, 257:327-388.
27. Fraser H.B., Khaitovich P., Plotkin J.B., Paabo S., Eisen M.B. Aging and gene expression in the primate brain. PLoS Biol. 2005, 3:274-287.
28. Fukumitsu H., Ohtsuka M., Murai R., Nakamura H., Itoh K., Furukawa S. Brain-derived neurotrophic factor participates in determination of neuronal laminar fate in the developing mouse cerebral cortex. J. Neurosci. 2006, 26:13218-13230.
29. Gallagher M., Colombo P.J. Ageing: the cholinergic hypothesis of cognitive decline. Curr. Opin. Neurobiol. 1995, 5:161-168.
30. Golden J.P., Milbrandt J., Johnson E.M. Neurturin and persephin promote the survival of embryonic basal forebrain cholinergic neurons in vitro. Exp. Neurol. 2003, 184:447-455.
31. Gómez-Palacio-Schjetnan A., Escobar M.L. In vivo BDNF modulation of adult functional and morphological synaptic plasticity at hippocampal mossy fibers. Neurosci. Lett. 2008, 445:62-67.
32. Hanstein R., Lu A., Wurst W., Holsboer F., Deussing J.M., Clement A.B., Behl C. Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress. Neuroscience 2008, 156:712-721.
33. Hattiangady B., Rao M.S., Zaman V., Shetty A.K. Incorporation of embryonic CA3 cell grafts into the adult hippocampus at 4-months after injury: effects of combined neurotrophic supplementation and caspase inhibition. Neuroscience 2006, 139:1369-1383.
34. Heaton M.B., Madorsky I., Paiva M., Mayer J. Influence of ethanol on neonatal cerebellum of BDNF gene-deleted animals: analyses of effects on Purkinje cells, apoptosis-related proteins, and endogenous antioxidants. J. Neurobiol. 2002, 51:160-176.
35. Hienola A., Pekkanen M., Raulo E., Vanttola P., Rauvala H. HB-GAM inhibits proliferation and enhances differentiation of neural stem cells. Mol. Cell. Neurosci. 2004, 26:75-88.
36. Holmberg K.H., Patterson P.H. Leukemia inhibitory factor is a key regulator of astrocytic, microglial and neuronal responses in a low-dose pilocarpine injury model. Brain Res. 2006, 1075:26-35.
37. Hosack D.A., Dennis G., Sherman B.T.H., Lane C.H., Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003, 4:R70.
38. Hsieh M.T., Hseih C.L., Lin L.W., Wu C.R., Huang G.S. Differential gene expression of scopolamine-treated rat hippocampus-application of cDNA microarray technology. Life Sci. 2003, 73:1007-1016.
39. Huh C.Y., Danik M., Manseau F., Trudeau L.E., Williams S. Chronic exposure to nerve growth factor increases acetylcholine and glutamate release from cholinergic neurons of the rat medial septum and diagonal band of Broca via mechanisms mediated by p75NTR. J. Neurosci. 2008, 28:1404-1409.
40. Imai F., Suzuki H., Oda J., Ninomiya T., Ono K., Sano H., Sawada M. Neuroprotective effect of exogenous microglia in global brain ischemia. J. Cereb. Blood Flow Metab. 2007, 27:488-500.
41. Iseki K., Hagino S., Mori T., Zhang Y., Yokoya S., Takaki H., Tase C., Murakawa M., Wanaka A. Increased syndecan expression by pleiotrophin and FGF receptor-expressing astrocytes in injured brain tissue. Glia 2002, 39:1-9.
42. Isono M., Goda M., Kobayashi H., Wu J.L. TGF-alpha overexpression induces astrocytic hypertrophy after cortical stab wound injury. Neurol. Res. 2003, 25:546-550.
43. Jin K., LaFevre-Bernt M., Sun Y., Chen S., Gafni J., Crippen D., Logvinova A., Ross C.A., Greenberg D.A., Ellerby L.M. FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18189-18194.
44. Johansson B.B. Brain plasticity in health and disease. Keio. J. Med. 2004, 53:231-246.
45. Khatri P., Draghici S., Ostermeier G.C., Krawetz S.A. Profiling gene expression using onto-express. Genomics 2002, 79:266-270.
46. Kiprianova I., Schindowski K., von Bohlen und Halbach O., Krause S., Dono R., Schwaninger M., Unsicker K. Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2. Exp. Neurol. 2004, 189:252-260.
47. Kohara K., Kitamura A., Adachi N., Nishida M., Itami C., Nakamura S., Tsumoto T. Inhibitory but not excitatory cortical neurons require presynaptic brain-derived neurotrophic factor for dendritic development, as revealed by chimera cell culture. J. Neurosci. 2003, 23:6123-6131.
48. Labelle C., Leclerc N. Exogenous BDNF, NT-3 and NT-4 differentially regulate neurite outgrowth in cultured hippocampal neurons. Brain Res. Dev. 2000, 123:1-11.
49. Langmade S.J., Gale S.E., Frolov A., Mohri I., Suzuki K., Mellon S.H., Walkley S.U., Covey D.F., Schaffer J.E., Ory D.S. Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:13807-13812.
50. Lee C.K., Weindruch R., Prolla T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 2000, 25:294-297.
51. Lesné S., Blanchet S., Docagne F., Liot G., Plawinski L., MacKenzie E.T., Auffray C., Buisson A., Piétu G., Vivien D. Transforming growth factor-beta1-modulated cerebral gene expression. J. Cereb. Blood Flow Metab. 2002, 22:1114-1123.
52. Lessmann V., Gottmann K., Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 2003, 69:341-374.
53. Lin T.N., Wang P.Y., Chi S.I., Kuo J.S. Differential regulation of ciliary neurotrophic factor (CNTF) and CNTF receptor alpha (CNTFR alpha) expression following focal cerebral ischemia. Mol Brain Res. 1998, 55:71-80.
54. Liot G., Gabriel C., Cacquevel M., Ali C., MacKenzie E.T., Buisson A., Vivien D. Neurotrophin-3-induced PI-3 kinase/Akt signaling rescues cortical neurons from apoptosis. Exp. Neurol. 2004, 187:38-46.
55. Ma P., Magut M., Chen X., Chen C.Y. P53 is necessary for the apoptotic response mediated by a transient increase of Ras activity. Mol. Cell Biol. 2002, 22:2928-2938.
56. Macias M. Injury induced dendritic plasticity in the mature central nervous system. Acta Neurobiol. Exp. (Wars) 2008, 68:334-346.
57. Mandolesi L., De Bartolo P., Foti F., Gelfo F., Federico F., Leggio M.G., Petrosini L. Environmental enrichment provides a cognitive reserve to be spent in the case of brain lesion. J. Alzheimers Dis. 2008, 15:11-28.
58. März P., Ozbek S., Fischer M., Voltz N., Otten U., Rose-John S. Differential response of neuronal cells to a fusion protein of ciliary neurotrophic factor/soluble CNTF-receptor and leukemia inhibitory factor. Eur. J. Biochem. 2002, 269:3023-3031.
59. Matsumura I., Tanaka H., Kanakura Y. E2F1 and c-Myc in cell growth and death. Cell Cycle 2003, 2:333-338.
60. McAllister A.K. Cellular and molecular mechanisms of dendrite growth. Cereb. Cortex. 2000, 10:963-973.
61. McCarroll S.A., Murphy C.T., Zou S., Pletcher S.D., Chin C.S., Jan Y.N., Kenyon C., Bargmann C.I., Li H. Comparing genomic expression patterns across species identifies shared transcriptional profile in aging. Nat. Genet. 2004, 36:197-204.
62. McGaughy J., Everitt B.J., Robbins T.W., Sarter M. The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav. Brain Res. 2000, 115:251-263.
63. Morrish F., Giedt C., Hockenbery D. c-MYC apoptotic function is mediated by NRF-1 target genes. Genes Dev. 2003, 17:240-255.
64. Morse J.K., Wiegand S.J., Anderson K., You Y., Cai N., Carnahan J., Miller J., DiStefano P.S., Altar C.A., Lindsay R.M., et al. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J. Neurosci. 1993, 13:4146-4156.
65. Muir J.L. Acetylcholine, aging, and Alzheimer's disease. Pharmacol. Biochem. Behav. 1997, 56:687-696.
66. Ozog M.A., Modha G., Church J., Reilly R., Naus C.C. Co-administration of ciliary neurotrophic factor with its soluble receptor protects against neuronal death and enhances neurite outgrowth. J. Biol. Chem. 2007, 283:6546-6560.
67. Paban V., Jaffard M., Chambon C., Malafosse M., Alescio-Lautier B. Time course of behavioral changes following basal forebrain cholinergic damage in rats: environmental enrichment as a therapeutic intervention. Neuroscience 2005, 132:13-32.
68. Paban V., Chambon C., Jaffard M., Alescio-Lautier B. Behavioral effects of basal forebrain cholinergic lesions in young adult and aging rats. Behav. Neurosci. 2005, 119:933-945.
69. Parent M.B., Baxter M.G. Septohippocampal acetylcholine: involved in but not necessary for learning and memory?. Learn Mem. 2004, 11:9-20.
70. Patz S., Wahle P. Neurotrophins induce short-term and long-term changes of cortical neurotrophin expression. Eur. J. Neurosci. 2004, 20:701-708.
71. Pencea V., Bingaman K.D., Freedman L.J., Luskin M.B. Neurogenesis in the subventricular zone and rostral migratory stream of the neonatal and adult primate forebrain. Exp. Neurol. 2001, 172:1-16.
72. Peria F.M., Neder L., Marie S.K., Rosemberg S., Oba-Shinjo S.M., Colli B.O., Gabbai A.A., Malheiros S.M., Zago M.A., Panepucci R.A., Moreira-Filho C.A., Okamoto O.K., Carlotti C.G. Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival. J. Neurooncol. 2007, 84:255-261.
73. Perry T., Hodges H., Gray J.A. Behavioural, histological and immunocytochemical consequences following 192 IgG-saporin immunolesions of the basal forebrain cholinergic system. Brain Res. Bull. 2001, 54:29-48.
74. Pizzo D.P., Thal L.J., Winkler J. Mnemonic deficits in animals depend upon the degree of cholinergic deficit and task complexity. Exp. Neurol. 2002, 177:292-305.
75. Presta M., Dell'Era P., Mitola S., Moroni E., Ronca R., Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005, 16:159-178.
76. Prolla T.A. DNA microarray analysis of the aging brain. Chem. Senses 2002, 27:299-306.
77. Ronnback A., Dahlqvist P., Svensson P.A., Jernas M., Carlsson B., Carlsson L.M., Olsson T. Gene expression profiling of the rat hippocampus one month after focal cerebral ischemia followed by enriched environment. Neurosci. Lett. 2005, 385:173-178.
78. Rossner S., Schliebs R., Hartig W., Bigl.V. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Brain Res. Bull. 1995, 38:371-381.
79. Rowe W.B., Blalock E.M., Chen K.C., Kadish I., Wang D., Barrett J.E., Thibault O., Porter N.M., Rose G.M., Landfield P.W. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J. Neurosci. 2007, 27:3098-3110.
80. Sarter M., Bruno J.P. Age-related changes in rodent cortical acetylcholine and cognition: main effects of age versus age as an intervening variable. Brain Res. Rev. 1998, 27:143-156.
81. Sarter M., Bruno J.P., Givens B. Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory?. Neurobiol. Learn Mem. 2003, 80:245-256.
82. Schindowski K., Belarbi K., Bretteville A., Ando K., Buée L. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation. Genes Brain Behav. 2008, 7:92-100.
83. Sheridan R.E., Adler M. Growth factor dependent cholinergic function and survival in primary mouse spinal cord cultures. Life Sci. 2006, 79:591-595.
84. Shinotoh H., Namba H., Fukushi K., Nagatsuka S., Tanaka N., Aotsuka A., Ota T., Tanada S., Irie T. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study. Ann. Neurol. 2000, 48:194-200.
85. Siegel J.M. Hypocretin (orexin): role in normal behavior and neuropathology. Annu. Rev. Psychol. 2004, 55:125-148.
86. Sleeman M.W., Anderson K.D., Lambert P.D., Yancopoulos G.D., Wiegand S.J. The ciliary neurotrophic factor and its receptor CNTFR alpha. Pharm. Acta Helv. 2000, 74:265-272.
87. Smith H.R., Pang K.C. Orexin-saporin lesions of the medial septum impair spatial memory. Neuroscience 2005, 132:261-271.
88. Sutcliffe J.G., De Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J. Neurosci. Res. 2000, 62:161-168.
89. Taupin P., Gage F.H. Adult neurogenesis and neural stem cells of the central nervous system in mammals. J. Neurosci. Res. 2002, 69:745-749.
90. Todd K.J., Auld D.S., Robitaille R. Neurotrophins modulate neuron-glia interactions at a vertebrate synapse. Eur. J. Neurosci. 2007, 25:1287-1296.
91. Tolwani R.J., Buckmaster P.S., Varma S., Cosgaya J.M., Wu Y., Suri C., Shooter E.M. BDNF overexpression increases dendrite complexity in hippocampal dentate gyrus. Neuroscience 2002, 114:795-805.
92. Torres E.M., Perry T.A., Blockland A., Wilkinson L.S., Wiley R.G., Lappi D.A., Dunnet S.B. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 1994, 63:95-122.
93. Troy C.M., Friedman J.E., Friedman W.J. Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases. J. Biol. Chem. 2002, 277:34295-34302.
94. Van Praag H., Kempermann G., Gage F.H. Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 2000, 1:191-198.
95. Waite J.J., Chen A.D. Differential changes in rat cholinergic parameters subsequent to immunotoxic lesion of the basal forebrain nuclei. Brain Res. 2001, 918:113-120.
96. Walsh T.J., Herzog C.D., Gandhi C., Stackman R.W., Wiley R.G. Injection of IgG 192-saporin into the medial septum produces cholinergic hypofunction and dose-dependent working memory deficits. Brain Res. 1996, 726:69-79.
97. Wang W., Redecker C., Bidmon H.J., Witte O.W. Delayed neuronal death and damage of GDNF family receptors in CA1 following focal cerebral ischemia. Brain Res. 2004, 1023:92-101.
98. Wang Y., Chang C.F., Morales M., Chiang Y.H., Hoffer J. Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Ann. N. Y. Acad. Sci. 2002, 962:423-437.
99. Wei X., Zhang Y., Zhou J. Alzheimer's disease-related gene expression in the brain of senescence accelerated mouse. Neurosci. Lett. 1999, 268:139-142.
100. Weindruch R., Kayo T., Lee C.K., Prolla T.A. Gene expression profiling of aging using DNA microarrays. Mech. Ageing 2002, 123:177-193.
101. Wenk G.L. The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiol. Learn Mem. 1997, 67:85-95.
102. Wrenn C.C., Wiley R.G. The behavioral functions of the cholinergic basal forebrain: lessons from 192 IgG-saporin. Int. J. Dev. Neurosci. 1998, 16:595-602.
103. Wu Z.L., Ciallella J.R., Flood D.G., O'Kane T.M., Bozyczko-Coyne D., Savage M.J. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Neurobiol. Aging 2006, 27:377-386.
104. Wu M., Zaborszky L., Hajszan T., Van Den Pol A.N., Alreja M. Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons. J. Neurosci. 2004, 24:3527-3536.
105. Xuan A.G., Long D.H., Gu H.G., Yang D.D., Hong L.P., Leng S.L. BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornix. Neurosci. Lett. 2008, 440:331-335.
106. Yan Z., Feng J. Alzheimer's disease: interactions between cholinergic functions and beta-amyloid. Curr. Alzheimer Res. 2004, 1:241-248.
107. Zeis T., Graumann U., Reynolds R., Schaeren-Wiemers N. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008, 131:288-303.
108. Zhang J., Zhang D., McQuade J.S., Behbehani M., Tsien J.Z., Xu M. c-fos regulates neuronal excitability and survival. Nat. Genet. 2002, 4:416-420.
109. Zhang W., Chen Y., Swift M.R., Tassi E., Stylianou D.C., Gibby K.A., Riegel A.T., Wellstein A. Effect of FGF binding protein-3 on vascular permeability. J. Biol. Chem. 2008, 283:28329-28337.
110. Zhang X. Cholinergic activity and amyloid precursor protein processing in aging and Alzheimer's disease. Curr. Drug Targets CNS Neurol. Disord. 2004, 3:137-152.